Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2020
vol. 95 abstract:
Case report
Kasabach-Merritt syndrome in an infant with cavernous haemangioma
Halyna Pavlyshyn
1
,
Nataliia Luchyshyn
1
Pediatr Pol 2020; 95 (1): 48–51
Online publish date: 2020/03/31
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Kasabach-Merritt syndrome (KMS) is a potentially life-threatening consumptive coagulopathy associated with vascular malformations, whereas haemangiomas typically present in infancy, with rapid growth, thoracic location, and complicated clinical course demanding chemotherapy and radiotherapy have rarely been reported. We describe a case of a female infant with cavernous haemangioma of the right chest wall spreading to the pleural space and diaphragm, and complicated by KMS. Our patient presented an inadequate response to treatment with systemic corticosteroids, propranolol, and vincristine. Partial tumour regression and diminish of trapping of platelets in the tumour were achieved after radiotherapy only. The purpose of this report is to increase awareness about KMS, to illustrate the treatment challenges and to provide a basis for clinical decision-making in this rare, life-threatening condition.
keywords:
Kasabach-Merritt syndrome, cavernous haemangioma, infant, management |